Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rapid Dose Therapeutics Corp (TSE:DOSE)
CNQX:DOSE
Rapid Dose Therapeutics Corp (DOSE) Stock Price & Analysis
5 Followers
DOSE Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.09 - C$0.28
Previous CloseC$0.19
Volume45.00K
Average Volume (3M)58.68K
Market Cap
C$23.24M
Enterprise ValueC$25.77M
Total Cash (Recent Filing)C$166.18K
Total Debt (Recent Filing)C$2.70M
Price to Earnings (P/E)―
Beta-0.34
Next Earnings
Jul 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding110,163,242
10 Day Avg. Volume57,165
30 Day Avg. Volume58,683
Standard Deviation0.38
R-Squared0.00820
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-4.98
Price to Sales (P/S)31.44
Price to Cash Flow (P/CF)-8.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Rapid Dose Therapeutics Corp News
PremiumCompany Announcements
Rapid Dose Therapeutics to Settle Interest with Shares
PremiumCompany Announcements
Rapid Dose Therapeutics Sees Revenue Surge
PremiumCompany Announcements
Rapid Dose Therapeutics Innovates Vaccine Delivery
PremiumCompany Announcements
Rapid Dose Extends Equity Financing Window
PremiumCompany Announcements
Innovative Drug Delivery System by RDT and McMaster
PremiumCompany Announcements
Rapid Dose Therapeutics Advances Funding Round
PremiumCompany Announcements
Rapid Dose Extends Financing WindowPremiumCompany Announcements
Rapid Dose Therapeutics Secures Additional FinancingOptions Prices
Currently, No data available
---
Ownership Overview
8.94% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
91.06% Public Companies and
Individual Investors
DOSE FAQ
What was Rapid Dose Therapeutics Corp’s price range in the past 12 months?
Rapid Dose Therapeutics Corp lowest stock price was C$0.09 and its highest was C$0.28 in the past 12 months.
What is Rapid Dose Therapeutics Corp’s market cap?
Currently, no data Available
When is Rapid Dose Therapeutics Corp’s upcoming earnings report date?
Rapid Dose Therapeutics Corp’s upcoming earnings report date is Jul 30, 2024 which is in 12 days.
How were Rapid Dose Therapeutics Corp’s earnings last quarter?
Currently, no data Available
Is Rapid Dose Therapeutics Corp overvalued?
According to Wall Street analysts Rapid Dose Therapeutics Corp’s price is currently Overvalued.
Does Rapid Dose Therapeutics Corp pay dividends?
Rapid Dose Therapeutics Corp does not currently pay dividends.
What is Rapid Dose Therapeutics Corp’s EPS estimate?
Rapid Dose Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rapid Dose Therapeutics Corp have?
Rapid Dose Therapeutics Corp has 122,297,134 shares outstanding.
What happened to Rapid Dose Therapeutics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rapid Dose Therapeutics Corp?
Currently, no hedge funds are holding shares in TSE:DOSE
---
Rapid Dose Therapeutics Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
15.15%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-16.09%
Trailing 12-Months
Company Description
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp is a bio-technology company, which through its subsidiaries, provides proprietary enhanced drug delivery technologies designed to improve patient outcomes. The company through its subsidiary, owns a proprietary oral fast-dissolving drug delivery system, QuickStrip, which is capable of rapidly releasing into the blood stream a variety of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver.
---
Technical Analysis
Heritage Cannabis Holdings Corp
―
Biome Grow Inc
―
TransCanna Holdings Inc
―
Better Plant Sciences
―
---